Flyout Menu
donate
MEMBER login
Facebook-f Twitter Linkedin-in Instagram

Highlights from American Diabetes Association (ADA) 2026 Scientific Sessions

Highlights from American Diabetes Association (ADA) 2026 Scientific Sessions

Highlights from ADA 2026 Scientific Sessions

Join us as we bring you the latest highlights from the American Diabetes Association (ADA) 2026 Scientific Sessions in New Orleans, LA, USA, taking place 5-8 June 2026!
Supported by an unrestricted educational grant from AstraZeneca, Boehringer Ingelheim and Lilly.

Highlights will be available at the end of the conference. Stay tuned!

Part 1

Ramzi Ajjan

Over-the-Counter Continuous Glucose Monitoring – Data for All or a Disaster Waiting to Happen?

Ramzi Ajjan

If You Had to Pick Just One – GLP-1RA, GIP/GLP-1RA or SGLT2i for Type 2 Diabetes?

Alex Viardot

Do GLP-1/GIP-RAs Worsen or Improve Mental Health and Suicidality?

Jonathan Shaw

Can We Improve the Quality of Weight Loss by Augmenting Fat Mass Loss while Preserving Lean Mass? The BELIEVE Study of Bimagrumab + Semaglutide

Tania Markovic

Why Are We Still Recommending Low-Fat Dairy?

Mark Cooper

Efficacy and Safety of CagriSema in Adults with Overweight/Obesity – The REDEFINE 1 and REDEFINE 2 Clinical Trials

Part 2

Thomas Kay

Innovating Stem Cell Manufacturing and Engraftment Strategies for Cell Replacement Therapy

Christopher Nolan

New Perspectives on Fetal and Placental Responses to Diabetes and Its Treatment

So-Hun Kim

Can We Improve the Quality of Weight Loss by Augmenting Fat Mass Loss while Preserving Lean Mass? The BELIEVE Study of Bimagrumab + Semaglutide

Tamara Milder

Can We Improve the Quality of Weight Loss by Augmenting Fat Mass Loss while Preserving Lean Mass? The BELIEVE Study of Bimagrumab + Semaglutide

Lee-Ling Lim

Lancet Journal Symposium – Early-Onset Type 2 Diabetes

Day 4

Day 4 highlights will be available soon. Stay tuned!

TBC

Diabetes Management & Treatment (T1D & T2D),
Diabetes Research

Webinar Search

Webinar Categories

Disclaimer: This webpage including the open access webinars is intended for use by healthcare professionals only. The presentations and its content cannot be reproduced, copied or provided to other third parties. Please contact the Australian Diabetes Society via email admin@diabetessociety.com.au for any enquiries.

ADS Professional Education Webinars

Disclaimer Notice

By agreeing to this disclaimer notice; you acknowledge that you are a registered healthcare professional accessing the open access clinical educational webinars hosted by the Australian Diabetes Society. The presentations and its content cannot be reproduced, copied or provided to other third parties. Please contact the Australian Diabetes Society via email admin@diabetessociety.com.au for any enquiries.

I ACCEPT
I DO NOT ACCEPT